Gastroenterology

Data Suggest Antibiotics, PPIs Blunt Anti-PD Activity



<![CDATA[]]>(MedPage Today) — Survival in advanced non-small cell lung cancer (NSCLC) declined significantly in patients treated with antibiotics or a proton pump inhibitor (PPI) at the same time they received a PD-L1 inhibitor, pooled data from two randomized…

Source link

Related posts

CME Exam 3: Risk of Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease

Newsemia

A Fluttering Blue Hue is Tough to Subdue

Newsemia

Bad mutants in IBD

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World